# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-20-095636
Filing Date
2020-08-14
Accepted
2020-08-14 17:07:45
Documents
62

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | tm2016252-23_424b4.htm | 424B4 | 4892906
2 | GRAPHIC | lg_curevacfpo-4clr.jpg | GRAPHIC | 40504
3 | GRAPHIC | tm2016252d19-fc_programs4c.jpg | GRAPHIC | 811987
4 | GRAPHIC | tm2016252d6_riderbofa42820.jpg | GRAPHIC | 387706
5 | GRAPHIC | tm2016252d6_fc-transfpo4c.jpg | GRAPHIC | 512034
6 | GRAPHIC | tm2016252d6_fc-bodyfpo4c.jpg | GRAPHIC | 394911
7 | GRAPHIC | tm2016252d6_fc-rnaooptfpo.jpg | GRAPHIC | 188317
8 | GRAPHIC | tm2016252d6_fc-exploongfpo.jpg | GRAPHIC | 223595
9 | GRAPHIC | tm2016252d6_lc-halffpo4c.jpg | GRAPHIC | 496744
10 | GRAPHIC | tm2016252d6_lc-half2fpo4c.jpg | GRAPHIC | 148797
11 | GRAPHIC | tm2016252d6_lc-prodesfpo4c.jpg | GRAPHIC | 103023
12 | GRAPHIC | tm2016252d6_fc-prodesfpo4c.jpg | GRAPHIC | 188729
13 | GRAPHIC | tm2016252d6_lc-modimfpo4c.jpg | GRAPHIC | 125271
14 | GRAPHIC | tm2016252d6_fc-sequence4c.jpg | GRAPHIC | 167979
15 | GRAPHIC | tm2016252d6-mrna.jpg | GRAPHIC | 161398
16 | GRAPHIC | tm2016252d6_bc-activfpo4c.jpg | GRAPHIC | 229630
17 | GRAPHIC | tm2016252d6-successive.jpg | GRAPHIC | 274950
18 | GRAPHIC | tm2016252d6_bc-optutrfpo4c.jpg | GRAPHIC | 117502
19 | GRAPHIC | tm2016252d6_bc-optorffpo4c.jpg | GRAPHIC | 160928
20 | GRAPHIC | tm2016252d6_bc-opt3endfpo4c.jpg | GRAPHIC | 137075
21 | GRAPHIC | tm2016252d6-diverse.jpg | GRAPHIC | 218699
22 | GRAPHIC | tm2016252d6_sc-vaclpnfpo.jpg | GRAPHIC | 303470
23 | GRAPHIC | tm2016252d6_sc-cvcmfpo4c.jpg | GRAPHIC | 179561
24 | GRAPHIC | tm2016252d6-cvcm.jpg | GRAPHIC | 135676
25 | GRAPHIC | tm2016252d6-production.jpg | GRAPHIC | 127751
26 | GRAPHIC | tm2016252d6_ph-buildfpo4c.jpg | GRAPHIC | 2379805
27 | GRAPHIC | tm2016252d6_ph-curevac4clr.jpg | GRAPHIC | 1604041
28 | GRAPHIC | tm2016252d6-ph_tumor4clr.jpg | GRAPHIC | 616245
29 | GRAPHIC | tm2016252d6-tbl_prelim4clr.jpg | GRAPHIC | 596008
30 | GRAPHIC | tm2016252d6-fc_cohorts4clr.jpg | GRAPHIC | 684971
31 | GRAPHIC | tm2016252d6-tbl_prefer4clr.jpg | GRAPHIC | 571212
32 | GRAPHIC | tm2016252d6-bc_prelim4clr.jpg | GRAPHIC | 2141159
33 | GRAPHIC | tm2016252d6_ph-melanfpo4c.jpg | GRAPHIC | 250665
34 | GRAPHIC | tm2016252d6-ph_lesions4clr.jpg | GRAPHIC | 279473
35 | GRAPHIC | tm2016252d6_ph-metafpo4c.jpg | GRAPHIC | 199853
36 | GRAPHIC | tm2016252d6_ph-pretrefpo4c.jpg | GRAPHIC | 130174
37 | GRAPHIC | tm2016252d6_lc-survfpo4c.jpg | GRAPHIC | 197463
38 | GRAPHIC | tm2016252d6_lc-tumorfpo4c.jpg | GRAPHIC | 152552
39 | GRAPHIC | tm2016252d6_lc-tumor2fpo4c.jpg | GRAPHIC | 180661
40 | GRAPHIC | tm2016252d6_lc-abscofpo4c.jpg | GRAPHIC | 179721
41 | GRAPHIC | tm2016252d6_fc-dosek.jpg | GRAPHIC | 168274
42 | GRAPHIC | tm2016252-6_riderg42820.jpg | GRAPHIC | 135900
43 | GRAPHIC | tm2016252d6-lc_cv72024c.jpg | GRAPHIC | 483505
44 | GRAPHIC | tm2016252d6-bc_sars4clr.jpg | GRAPHIC | 201098
45 | GRAPHIC | tm2016252d6-bc_induc4clr.jpg | GRAPHIC | 528620
46 | GRAPHIC | tm2016252d6-bc_kinet4clr.jpg | GRAPHIC | 993673
47 | GRAPHIC | tm2016252-6_riderf42820.jpg | GRAPHIC | 40922
48 | GRAPHIC | tm2016252d6_lc-influenfpo4c.jpg | GRAPHIC | 384598
49 | GRAPHIC | tm2016252d6_bc-servntfpoo4c.jpg | GRAPHIC | 317224
50 | GRAPHIC | tm2016252d6_bc-lungfpoo4c.jpg | GRAPHIC | 250006
51 | GRAPHIC | tm2016252d6_fc-liverfpo4c.jpg | GRAPHIC | 124269
52 | GRAPHIC | tm2016252d6_sc-25hcfpo4c.jpg | GRAPHIC | 178879
53 | GRAPHIC | tm2016252d6_fc-therafpo4c.jpg | GRAPHIC | 726221
54 | GRAPHIC | tm2016252d6_lc-aminofpo4c.jpg | GRAPHIC | 171145
55 | GRAPHIC | tm2016252d6_ph-ccl4fpo4c.jpg | GRAPHIC | 551026
56 | GRAPHIC | tm2016252d6_lc-dfpo4c.jpg | GRAPHIC | 74949
57 | GRAPHIC | tm2016252d6_lc-gfpo4c.jpg | GRAPHIC | 83627
58 | GRAPHIC | tm2016252d6_lc-rituxfpo4c.jpg | GRAPHIC | 115145
59 | GRAPHIC | tm2016252d6_fc-retinafpo4c.jpg | GRAPHIC | 277281
60 | GRAPHIC | tm2016252d6_sc-areabuff.jpg | GRAPHIC | 636142
61 | GRAPHIC | tm2016252d6_bc-levelsfpo4c.jpg | GRAPHIC | 185529
62 | GRAPHIC | lg_curevac-fpo.jpg | GRAPHIC | 79401
| Complete submission text file | 0001104659-20-095636.txt |  | 35691528

Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-240076 | Film No.: 201106460
SIC: 2834 Pharmaceutical Preparations